ProShares Ultra Health Care
16 hedge funds and large institutions have $2.79M invested in ProShares Ultra Health Care in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
10.65% less ownership
Funds ownership: 14.53% → 3.88% (-11%)
20% less funds holding
Funds holding: 20 → 16 (-4)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
60% less capital invested
Capital invested by funds: $7M → $2.79M (-$4.21M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPIA
Steward Partners Investment Advisory
New York
|
+$20.1K |
| 2 |
CIAS
Capital Investment Advisory Services
Raleigh,
North Carolina
|
+$552 |
| 3 |
AIC
Archer Investment Corporation
Carmel,
Indiana
|
+$100 |
| 4 |
Morgan Stanley
New York
|
+$100 |
| 5 |
HFS
Hantz Financial Services
Southfield,
Michigan
|
+$50 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$1.03M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$876K |
| 3 |
IMC Chicago
Chicago,
Illinois
|
-$521K |
| 4 |
Jane Street
New York
|
-$364K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$234K |
RXL Hedge Fund Activity: Q4 2024 in Review
16 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q4 2024, worth a combined $2.79M — down 60% from $7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RXL and 1 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Steward Partners Investment Advisory, adding an estimated $20.1K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $1.03M sold.
- 16 institutional investors held ProShares Ultra Health Care (RXL) as of Q4 2024, down from 20 in Q3 2024.
- Funds reported $2.79M of ProShares Ultra Health Care stock for Q4 2024, down 60% quarter-over-quarter.
- 1 fund opened new ProShares Ultra Health Care positions in Q4 2024 and 5 closed out, a net change of -4 holders.
- The largest ProShares Ultra Health Care buyer in Q4 2024 was Steward Partners Investment Advisory, an estimated $20.1K added.
- The largest ProShares Ultra Health Care seller in Q4 2024 was Envestnet Asset Management, an estimated $1.03M sold.
Based on aggregated 13F filings for Q4 2024.